.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Evaluate market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Claims for Patent: 7,786,158

« Back to Dashboard

Claims for Patent: 7,786,158

Title:Compounds as opioid receptor modulators
Abstract: The present invention is directed to novel opioid receptor modulators of Formula (I). ##STR00001## The invention further relates to methods for preparing such compounds, pharmaceutical compositions containing them, and their use in the treatment of disorders that may be ameliorated or treated by the modulation of opioid receptors.
Inventor(s): Breslin; Henry J. (Lansdale, PA), Cai; Chaozhong (N. Wales, PA), He; Wei (Audobon, PA), Kavash; Robert W. (Glenside, PA)
Assignee: Janssen Pharmaceutica N.V. (Beerse, BE)
Application Number:11/877,747
Patent Claims: 1. A compound of Formula (I) ##STR00046## wherein: R.sup.1 is selected from the group consisting of hydrogen, C.sub.1-6alkyl, cycloalkyl, heterocyclyl, aryl(C.sub.1-6)alkyl, and heteroaryl(C.sub.1-6)alkyl; wherein when R.sup.1 is phenyl(C.sub.1-6)alkyl, phenyl is optionally fused to a heterocyclyl or cycloalkyl; wherein when R.sup.1 is C.sub.1-2alkyl, said C.sub.1-2alkyl is optionally substituted with one to two substituents independently selected from the group consisting of C.sub.1-6alkoxy, aryl, cycloalkyl, heterocyclyl, hydroxy, cyano, amino, C.sub.1-6alkylamino, (C.sub.1-6alkyl).sub.2amino, trifluoromethyl, and carboxy; and further, wherein when R.sup.1 is C.sub.3-6alkyl, said C.sub.3-6alkyl is optionally substituted with one to three substituents independently selected from the group consisting of C.sub.1-6alkoxy, aryl, cycloalkyl, heterocyclyl, hydroxy, cyano, amino, C.sub.1-6alkylamino, (C.sub.1-6alkyl).sub.2amino, trifluoromethyl, and carboxy; wherein the cycloalkyl and heterocyclyl of C.sub.1-2alkyl and C.sub.3-6alkyl are optionally substituted with one to two substituents independently selected from the group consisting of C.sub.1-6alkyl, hydroxy(C.sub.1-6)alkyl, C.sub.1-6alkoxy, hydroxy, cyano, amino, C.sub.1-6alkylamino, (C.sub.1-6alkyl).sub.2amino, trifluoromethyl, carboxy, aryl(C.sub.1-6)alkoxycarbonyl, C.sub.1-6alkoxycarbonyl, aminocarbonyl, C.sub.1-6alkylaminocarbonyl, (C.sub.1-6alkyl).sub.2aminocarbonyl, and aminosulfonyl; furthermore, wherein the cycloalkyl and heterocyclyl of R.sup.1 are optionally substituted with one to two substituents independently selected from the group consisting of C.sub.1-6alkyl, hydroxy(C.sub.1-6)alkyl, C.sub.1-6alkoxy, hydroxy, cyano, amino, C.sub.1-6alkylamino, (C.sub.1-6alkyl).sub.2amino, trifluoromethyl, carboxy, aryl(C.sub.1-6)alkoxycarbonyl, C.sub.1-6alkoxycarbonyl, aminocarbonyl, C.sub.1-6alkylaminocarbonyl, (C.sub.1-6alkyl).sub.2aminocarbonyl, and aminosulfonyl; furthermore, wherein the aryl and heteroaryl portion of the R.sup.1 substituents aryl(C.sub.1-6)alkyl and heteroaryl(C.sub.1-6)alkyl, are optionally substituted with one to three R.sup.11 substituents independently selected from the group consisting of C.sub.1-6alkyl; hydroxy(C.sub.1-6)alkyl; C.sub.1-6alkoxy; C.sub.6-10aryl(C.sub.1-6)alkyl; C.sub.6-10aryl(C.sub.1-6)alkoxy; C.sub.6-10aryl; heteroaryl optionally substituted with one to two substituents independently selected from the group consisting of C.sub.1-4alkyl, C.sub.1-4alkoxy, and carboxy; cycloalkyl; heterocyclyl; C.sub.6-10aryloxy; heteroaryloxy; cycloalkyloxy; heterocyclyloxy; amino; C.sub.1-6alkylamino; (C.sub.1-6alkyl).sub.2amino; C.sub.3-6cycloalkylaminocarbonyl; hydroxy(C.sub.1-6)alkylaminocarbonyl; C.sub.6-10arylaminocarbonyl wherein C.sub.6-10aryl is optionally substituted with carboxy or C.sub.1-4alkoxycarbonyl; heterocyclylcarbonyl; carboxy; C.sub.1-6alkoxycarbonyl; C.sub.1-6alkoxycarbonyloxy; C.sub.1-6alkylcarbonyl; C.sub.1-6alkylcarbonylamino; aminocarbonyl; C.sub.1-6alkylaminocarbonyl; (C.sub.1-6alkyl).sub.2aminocarbonyl; cyano; halogen; trifluoromethyl; trifluoromethoxy; and hydroxy; provided that no more than one R.sup.11 substituent is selected from the group consisting of C.sub.6-10aryl(C.sub.1-6)alkyl; C.sub.6-10aryl(C.sub.1-6)alkoxy; C.sub.6-10aryl; heteroaryl optionally substituted with one to two substituents independently selected from the group consisting of C.sub.1-4alkyl, C.sub.1-4alkoxy, and carboxy; cycloalkyl; heterocyclyl; C.sub.6-10aryloxy; heteroaryloxy; cycloalkyloxy; C.sub.6-10arylaminocarbonyl wherein C.sub.6-10aryl is optionally substituted with carboxy or C.sub.1-4alkoxycarbonyl; heterocyclylcarbonyl, and heterocyclyloxy; R.sup.2 is hydrogen, C.sub.1-8alkyl, hydroxy(C.sub.1-8)alkyl, C.sub.6-10aryl(C.sub.1-6)alkoxy(C.sub.1-6)alkyl, or C.sub.6-10aryl(C.sub.1-8)alkyl; wherein the C.sub.6-10aryl group in the C.sub.6-10aryl-containing substituents of R.sup.2 are optionally substituted with one to two substituents independently selected from the group consisting of C.sub.1-6alkyl, C.sub.1-6alkoxy, hydroxy, amino, C.sub.1-6alkylamino, (C.sub.1-6alkyl).sub.2amino, aminocarbonyl, C.sub.1-6alkylaminocarbonyl, (C.sub.1-6alkyl).sub.2aminocarbonyl, cyano, fluoro, chloro, bromo, trifluoromethyl, and trifluoromethoxy; and, wherein the C.sub.1-6alkyl and C.sub.1-6alkoxy substituents of aryl are optionally substituted with hydroxy, amino, C.sub.1-6alkylamino, (C.sub.1-6alkyl).sub.2amino, or aryl; A is a-1; ##STR00047## wherein A-B is selected from the group consisting of N--C; R.sup.3 is one to two substituents independently selected from the group consisting of C.sub.1-6alkyl, aryl, aryl(C.sub.1-6)alkyl, aryl(C.sub.2-6)alkenyl, aryl(C.sub.2-6)alkynyl, heteroaryl, heteroaryl(C.sub.1-6)alkyl, heteroaryl(C.sub.2-6)alkenyl, heteroaryl(C.sub.2-6)alkynyl, amino, C.sub.1-6alkylamino, (C.sub.1-6alkyl).sub.2amino, arylamino, heteroarylamino, aryloxy, heteroaryloxy, trifluoromethyl, and halogen; wherein the aryl, heteroaryl, and the aryl and heteroaryl of aryl(C.sub.1-6)alkyl, aryl(C.sub.2-6)alkenyl, aryl(C.sub.2-6)alkynyl, heteroaryl(C.sub.1-6)alkyl, heteroaryl(C.sub.2-6)alkenyl, heteroaryl(C.sub.2-6)alkynyl, arylamino, heteroarylamino, aryloxy, and heteroaryloxy, are optionally substituted with one to five fluoro substituents or one to three substituents independently selected from the group consisting of C.sub.1-6alkyl, hydroxy(C.sub.1-6)alkyl, C.sub.1-6alkoxy, C.sub.6-10aryl(C.sub.1-6)alkyl, C.sub.6-10aryl(C.sub.1-6)alkoxy, C.sub.6-10aryl, C.sub.6-10aryloxy, heteroaryl(C.sub.1-6)alkyl, heteroaryl(C.sub.1-6)alkoxy, heteroaryl, heteroaryloxy, C.sub.6-10arylamino, heteroarylamino, amino, C.sub.1-6alkylamino, (C.sub.1-6alkyl).sub.2amino, carboxy(C.sub.1-6)alkylamino, carboxy, C.sub.1-6alkylcarbonyl, C.sub.1-6alkoxycarbonyl, C.sub.1-6alkylcarbonylamino, aminocarbonyl, C.sub.1-6alkylaminocarbonyl, (C.sub.1-6alkyl).sub.2aminocarbonyl, carboxy(C.sub.1-6)alkylaminocarbonyl, cyano, halogen, trifluoromethyl, trifluoromethoxy, hydroxy, C.sub.1-6alkylsulfonyl, and C.sub.1-6alkylsulfonylamino; provided that no more than one such substituent on the aryl or heteroaryl portion of R.sup.3 is selected from the group consisting of C.sub.6-10aryl(C.sub.1-6)alkyl, C.sub.6-10aryl(C.sub.1-6)alkoxy, C.sub.6-10aryl, C.sub.6-10aryloxy, heteroaryl(C.sub.1-6)alkyl, heteroaryl(C.sub.1-6)alkoxy, heteroaryl, heteroaryloxy, C.sub.6-10arylamino, heteroarylamino; and wherein C.sub.1-6alkyl and C.sub.1-6alkyl of aryl(C.sub.1-6)alkyl and heteroaryl(C.sub.1-6)alkyl are optionally substituted with a substituent selected from the group consisting of hydroxy, carboxy, C.sub.1-4alkoxycarbonyl, amino, C.sub.1-6alkylamino, (C.sub.1-6alkyl).sub.2amino, aminocarbonyl, (C.sub.1-4)alkylaminocarbonyl, di(C.sub.1-4)alkylaminocarbonyl, aryl, heteroaryl, arylamino, heteroarylamino, aryloxy, heteroaryloxy, aryl(C.sub.1-4)alkoxy, and heteroaryl(C.sub.1-4)alkoxy; R.sup.4 is C.sub.6-10aryl or a heteroaryl selected from the group consisting of furyl, thienyl, pyrrolyl, oxazolyl, thiazolyl, imidazolyl, pyrazolyl, pyridinyl, pyrimidinyl, pyrazinyl, indolyl, isoindolyl, indolinyl, benzofuryl, benzothienyl, benzimidazolyl, benzthiazolyl, benzoxazolyl, quinolizinyl, quinolinyl, isoquinolinyl and quinazolinyl; wherein R.sup.4 is optionally substituted with one to three R.sup.41 substituents independently selected from the group consisting of (C.sub.1-6)alkyl optionally substituted with amino, C.sub.1-6alkylamino, or (C.sub.1-6alkyl).sub.2amino; (C.sub.1-6)alkoxy; phenyl(C.sub.1-6)alkoxy; phenyl(C.sub.1-6)alkylcarbonyloxy wherein C1-6 alkyl is optionally substituted with amino; a non fused 5-membered-heteroaryl(C.sub.1-6)alkylcarbonyloxy; a non fused 5-membered-heteroaryl; hydroxy; halogen; aminosulfonyl; formylamino; aminocarbonyl; C.sub.1-6alkylaminocarbonyl wherein (C.sub.1-6)alkyl is optionally substituted with amino, C.sub.1-6alkylamino, or (C.sub.1-6alkyl).sub.2amino; (C.sub.1-6alkyl).sub.2aminocarbonyl wherein each (C.sub.1-6)alkyl is optionally substituted with amino, C.sub.1-6alkylamino, or (C.sub.1-6alkyl).sub.2amino; heterocyclylcarbonyl wherein heterocyclyl is a 5-7 membered nitrogen-containing ring and said heterocyclyl is attached to the carbonyl carbon via a nitrogen atom; carboxy; or cyano; and wherein the phenyl portion of phenyl(C.sub.1-6)alkylcarbonyloxy is optionally substituted with (C.sub.1-6)alkyl (C.sub.1-6)alkoxy, halogen, cyano, amino, or hydroxy; provided that no more than one R.sup.41 is C.sub.1-6alkyl substituted with C.sub.1-6alkylamino or (C.sub.1-6alkyl).sub.2amino; aminosulfonyl; formylamino; aminocarbonyl; C.sub.1-6alkylaminocarbonyl; C.sub.1-6alkyl).sub.2aminocarbonyl; heterocyclylcarbonyl; hydroxy; carboxy; or a phenyl- or heteroaryl-containing substituent; R.sup.5 is a substituent on a nitrogen atom of ring A selected from the group consisting of hydrogen and C.sub.1-4alkyl; R.sup.6 is hydrogen or C.sub.1-6alkyl; R.sup.7 is hydrogen or C.sub.1-6alkyl; R.sup.a and R.sup.b are independently selected from the group consisting of hydrogen, C.sub.1-6alkyl, and C.sub.1-6alkoxycarbonyl; alternatively, when R.sup.a and R.sup.b are each other than hydrogen, R.sup.a and R.sup.b are optionally taken together with the nitrogen atom to which they are both attached to form a five to eight membered monocyclic ring; L is selected from the group consisting of O; and pharmaceutically acceptable enantiomers, diastereomers, racemates, and salts thereof.

2. The compounds of claim 1 wherein R.sup.1 is selected from the group consisting of hydrogen, C.sub.1-6alkyl, aryl(C.sub.1-4)alkyl, and heteroaryl(C.sub.1-4)alkyl; wherein the aryl and heteroaryl portion of aryl(C.sub.1-4)alkyl and heteroaryl(C.sub.1-4)alkyl are optionally substituted with one to three R.sup.11 substituents independently selected from the group consisting of C.sub.1-6alkoxy; heteroaryl optionally substituted with one to two substitutents independently selected from the group consisting of C.sub.1-4alkyl, C.sub.1-4alkoxy, and carboxy; carboxy; C.sub.1-4alkoxycarbonyl; C.sub.1-4alkoxycarbonyloxy; aminocarbonyl; C.sub.1-4alkylaminocarbonyl; C.sub.3-6cycloalkylaminocarbonyl; hydroxy(C.sub.1-6)alkylaminocarbonyl; C.sub.6-10arylaminocarbonyl wherein C.sub.6-10aryl is optionally substituted with carboxy or C.sub.1-4alkoxycarbonyl; heterocyclylcarbonyl; cyano; halogen; trifluoromethoxy; and hydroxy; provided that no more than one R.sup.11 is heteroaryl (optionally substituted with one to two C.sub.1-4alkyl substituents); C.sub.6-10arylaminocarbonyl wherein C.sub.6-10aryl is optionally substituted with carboxy or C.sub.1-4alkoxycarbonyl; or heterocyclylcarbonyl.

3. The compounds of claim 1 wherein R.sup.1 is selected from the group consisting of C.sub.6-10aryl(C.sub.1-4)alkyl, pyridinyl(C.sub.1-4)alkyl, and furanyl(C.sub.1-4)alkyl; wherein C.sub.6-10aryl, pyridinyl, and furanyl are optionally substituted with one to three R.sup.11 substituents independently selected from the group consisting of C.sub.1-3alkoxy; tetrazolyl; carboxy; C.sub.1-4alkoxycarbonyl; aminocarbonyl; C.sub.1-4alkylaminocarbonyl; C.sub.1-3alkylaminocarbonyl; C.sub.3-6cycloalkylaminocarbonyl; hydroxy(C.sub.1-4)alkylaminocarbonyl; C.sub.6-10arylaminocarbonyl wherein C.sub.6-10aryl is optionally substituted with carboxy or C.sub.1-4alkoxycarbonyl; morpholin-4-ylcarbonyl; cyano; halogen; and trifluoromethoxyl; provided that no more than one R.sup.11 is C.sub.6-10arylaminocarbonyl.

4. The compounds of claim 1 wherein R.sup.1 is selected from the group consisting of phenyl(C.sub.1-3)alkyl, pyridinyl(C.sub.1-3)alkyl, and furanyl(C.sub.1-3)alkyl; wherein phenyl, pyridinyl, and furanyl are optionally substituted with one to three R.sup.11 substituents independently selected from the group consisting of C.sub.1-3alkoxy; tetrazolyl, C.sub.3-6cycloalkylaminocarbonyl; hydroxy(C.sub.1-4)alkylaminocarbonyl; C.sub.6-10arylaminocarbonyl wherein C.sub.6-10aryl is optionally substituted with carboxy or C.sub.1-4alkoxycarbonyl; morpholin-4-ylcarbonyl; chloro; fluoro; trifluoromethoxy; C.sub.1-4alkoxycarbonyl; and carboxy; provided that no more than one R.sup.11 is C.sub.6-10arylaminocarbonyl.

5. The compounds of claim 1 wherein R.sup.1 is phenylmethyl, pyridinylmethyl, or furanylmethyl; wherein phenyl, pyridinyl, and furanyl are optionally substituted with one to three R.sup.11 substituents independently selected from the group consisting of methoxy; tetrazolyl; cyclopropylaminocarbonyl; (2-hydroxyeth-1-yl)aminocarbonyl; methoxycarbonyl; phenylaminocarbonyl wherein phenyl is optionally substituted with carboxy; morpholin-4-ylcarbonyl; and carboxy.

6. The compounds of claim 1 wherein R.sup.2 is a substituent selected from the group consisting of hydrogen, C.sub.1-4alkyl, hydroxy(C.sub.1-4)alkyl, and phenyl(C.sub.1-6)alkoxy(C.sub.1-4)alkyl; wherein said phenyl is optionally substituted with one to two substituents independently selected from the group consisting of C.sub.1-3alkyl, C.sub.1-3alkoxy, hydroxy, cyano, fluoro, chloro, bromo, trifluoromethyl, and trifluoromethoxy.

7. The compounds of claim 1 wherein R.sup.2 is a substituent selected from the group consisting of hydrogen and C.sub.1-4alkyl.

8. The compounds of claim 1 wherein R.sup.2 is hydrogen or methyl.

9. The compounds of claim 1 wherein R.sup.3 is one to two substituents independently selected from the group consisting of C.sub.1-6alkyl, halogen, and aryl; wherein aryl is optionally substituted with one to three substituents independently selected from the group consisting of halogen, carboxy, aminocarbonyl, C.sub.1-3alkylsulfonylamino, cyano, hydroxy, amino, C.sub.1-3alkylamino, and (C.sub.1-3alkyl).sub.2amino.

10. The compounds of claim 1 wherein R.sup.3 is one to two substituents independently selected from the group consisting of C.sub.1-3alkyl, bromo, and phenyl; wherein phenyl is optionally substituted with one to three substituents independently selected from the group consisting of chloro, fluoro, iodo, carboxy, aminocarbonyl, and cyano.

11. The compounds of claim 1 wherein R.sup.3 is one to two substituents independently selected from the group consisting of methyl and phenyl; wherein phenyl is optionally substituted with one to three substituents independently selected from the group consisting of chloro and carboxy.

12. The compounds of claim 1 wherein at least one R.sup.3 substituent is phenyl.

13. The compounds of claim 1 wherein R.sup.3 is a substituent selected from the group consisting of methyl and phenyl; wherein phenyl is optionally substituted with one to two substituents independently selected from the group consisting of chloro and carboxy.

14. The compounds of claim 1 wherein R.sup.4 is C.sub.6-10aryl optionally substituted with one to three R.sup.41 substituents independently selected from the group consisting of (C.sub.1-3)alkyl, (C.sub.1-6)alkoxy, phenyl(C.sub.1-6)alkoxy; hydroxy; halogen; formylamino; aminocarbonyl; C.sub.1-6alkylaminocarbonyl; (C.sub.1-6alkyl).sub.2aminocarbonyl; heterocyclylcarbonyl wherein heterocyclyl is a 5-7 membered nitrogen-containing ring and said heterocyclyl is attached to the carbonyl carbon via a nitrogen atom; carboxy; and cyano; provided that no more than one R.sup.41 substituent is formylamino, aminocarbonyl, C.sub.1-6alkylaminocarbonyl, (C.sub.1-6alkyl).sub.2aminocarbonyl, heterocyclylcarbonyl, hydroxy, carboxy, or a phenyl-containing substituent.

15. The compounds of claim 1 wherein R.sup.4 is phenyl substituted with one to three R.sup.41 substituents independently selected from the group consisting of (C.sub.1-3)alkyl, (C.sub.1-3)alkoxy, phenyl(C.sub.1-3)alkoxy, hydroxy, C.sub.1-6alkylaminocarbonyl, and aminocarbonyl; provided that no more than one R.sup.41 substituent is aminocarbonyl, C.sub.1-6alkylaminocarbonyl, hydroxy, or a phenyl-containing substituent.

16. The compounds of claim 1 wherein R.sup.4 is phenyl substituted at the 4-position with hydroxy, C.sub.1-3alkylaminocarbonyl, or aminocarbonyl, and optionally substituted with one to two substituents independently selected from the group consisting of methyl, methoxy, and benzyloxy.

17. The compounds of claim 1 wherein R.sup.4 is phenyl substituted at the 4-position with hydroxy, C.sub.1-3alkylaminocarbonyl, or aminocarbonyl, and optionally substituted with one to two methyl substituents.

18. The compounds of claim 1 wherein R.sup.4 is phenyl substituted at the 4-position with hydroxy, C.sub.1-3alkylaminocarbonyl, or aminocarbonyl, and substituted at the 2- and 6-positions with methyl substituents.

19. The compounds of claim 1 wherein R.sup.5 is hydrogen or methyl.

20. The compounds of claim 1 wherein R.sup.5 is hydrogen.

21. The compounds of claim 1 wherein R.sup.6 is hydrogen or methyl.

22. The compounds of claim 1 wherein R.sup.6 is hydrogen.

23. The compounds of claim 1 wherein R.sup.7 is hydrogen or methyl.

24. The compounds of claim 1 wherein R.sup.7 is hydrogen.

25. The compounds of claim 1 wherein R.sup.a and R.sup.b are independently selected from the group consisting of hydrogen and C.sub.1-3alkyl; or, when R.sup.a and R.sup.b are each other than hydrogen, R.sup.a and R.sup.b are optionally taken together with the nitrogen atom to which they are both attached to form a five to seven membered monocyclic ring.

26. The compounds of claim 1 wherein R.sup.a and R.sup.b are independently hydrogen or methyl.

27. The compounds of claim 1 wherein R.sup.a and R.sup.b are each hydrogen.

28. The compounds of claim 1 that are present in their RR, SS, RS, and SR configurations.

29. The compounds of claim 1 in their S,S configuration.
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc